Is there a simple comparison of duration, cost, coverage, and generics for ADHD meds in Canada?

There is no simple national table that ranks duration, cost, coverage, and generics for ADHD medicines in Canada. Duration, public listing, private insurance, and out-of-pocket cost are different questions, and mixing them into one ranking is misleading. For duration and line of therapy, CADDRA publishes a medication chart with approximate hours, release notes, and which products are first-line long-acting stimulants versus second-line or other options. References: https://www.caddra.ca/medication-chart/ https://www.caddra.ca/provincial-and-federal-public-formulary-overview/ https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/programs/limited-coverage-drug-program/limited-coverage-drugs-methylphenidate https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/programs/limited-coverage-drug-program/limited-coverage-drugs-dextroamphetamine-amphetamine

I went looking for one Canada spreadsheet of hours versus price versus coverage and did not find it. What actually helped was the CADDRA chart for a rough duration picture, then my provincial formulary search, then a call to the insurance line. BC listing for one methylphenidate product was not the same as what a friend in Ontario described. The pharmacist refused to quote a simple monthly cost without the dose and plan. I stopped trying to rank meds by dollars. This is only how I looked it up, not a national answer.